Zhou H - Search Results

1

A Nomogram to Predict the Pathologic Complete Response of Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Based on Simple Laboratory Indicators.

Zhang F, Huang M, Zhou H, Chen K, Jin J, Wu Y, Ying L, Ding X, Su D, Zou D. Zhang F, et al. Among authors: zhou h. Ann Surg Oncol. 2019 Nov;26(12):3912-3919. doi: 10.1245/s10434-019-07655-7. Epub 2019 Jul 29. Ann Surg Oncol. 2019. PMID: 31359285

2

Plasma cell-free DNA chromosomal instability analysis by low-pass whole-genome sequencing to monitor breast cancer relapse.

Zhou H, Wang XJ, Jiang X, Qian Z, Chen T, Hu Y, Chen ZH, Gao Y, Wang R, Ye WW, Cao WM. Zhou H, et al. Breast Cancer Res Treat. 2019 Nov;178(1):63-73. doi: 10.1007/s10549-019-05375-w. Epub 2019 Jul 30. Breast Cancer Res Treat. 2019. PMID: 31364001

3

Advancements in research and clinical management of interstitial lung injury associated with ADC drugs administration in breast cancer.

Zhu JY, Jiang RY, Zhang HP, Fang ZR, Zhou HH, Wei Q, Wang X. Zhu JY, et al. Discov Oncol. 2024 Dec 27;15(1):843. doi: 10.1007/s12672-024-01705-7. Discov Oncol. 2024. PMID: 39729236 Free PMC article. Review.

4

Transient Elastography (FibroScan) Performs Better Than Non-Invasive Markers in Assessing Liver Fibrosis and Cirrhosis in Autoimmune Hepatitis Patients.

Guo L, Zheng L, Hu L, Zhou H, Yu L, Liang W. Guo L, et al. Among authors: zhou h. Med Sci Monit. 2017 Oct 26;23:5106-5112. doi: 10.12659/msm.907300. Med Sci Monit. 2017. PMID: 29073121 Free PMC article.

5

Prognostic significance of mammary Paget's disease in Chinese women: a 10-year, population-based, matched cohort study.

Zhou H, Lu K, Zheng L, Guo L, Gao Y, Miao X, Chen Z, Wang X. Zhou H, et al. Onco Targets Ther. 2018 Nov 23;11:8319-8326. doi: 10.2147/OTT.S171710. eCollection 2018. Onco Targets Ther. 2018. PMID: 30538501 Free PMC article.

6

Cardiac Safety in Breast Cancer Patients Receiving Pegylated Liposome Doxorubicin Sequential Anti-HER2 Monoclonal Antibody Therapy.

Huang P, Huang JH, Zheng YB, Cao WM, Shao XY, Chen JQ, Huang Y, Li GL, Sharma K, Zhou HH, Wang XJ, Jin HC, Chen ZH. Huang P, et al. Front Pharmacol. 2022 Aug 4;13:883600. doi: 10.3389/fphar.2022.883600. eCollection 2022. Front Pharmacol. 2022. PMID: 35991878 Free PMC article.

7

PI3K/AKT/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancer.

Zhang HP, Jiang RY, Zhu JY, Sun KN, Huang Y, Zhou HH, Zheng YB, Wang XJ. Zhang HP, et al. Breast Cancer. 2024 Jul;31(4):539-551. doi: 10.1007/s12282-024-01567-5. Epub 2024 Apr 17. Breast Cancer. 2024. PMID: 38630392 Free PMC article. Review.

8

Long non-coding RNA FOXD3 antisense RNA 1 augments anti-estrogen resistance in breast cancer cells through the microRNA-363/ trefoil factor 1/ phosphatidylinositol 3-kinase/protein kinase B axis.

Ren L, Zhou H, Lei L, Zhang Y, Cai H, Wang X. Ren L, et al. Among authors: zhou h. Bioengineered. 2021 Dec;12(1):5266-5278. doi: 10.1080/21655979.2021.1962694. Bioengineered. 2021. PMID: 34424807 Free PMC article.

9

Application and progress of 3D tumor models in breast cancer.

Xu J, Fang W, Zhou H, Jiang R, Chen Z, Wang X. Xu J, et al. Among authors: zhou h. Biotechnol Bioeng. 2025 Jan;122(1):30-43. doi: 10.1002/bit.28860. Epub 2024 Oct 14. Biotechnol Bioeng. 2025. PMID: 39402769 Review.

10

STAT3: Key targets of growth-promoting receptor positive breast cancer.

Jiang RY, Zhu JY, Zhang HP, Yu Y, Dong ZX, Zhou HH, Wang X. Jiang RY, et al. Cancer Cell Int. 2024 Oct 28;24(1):356. doi: 10.1186/s12935-024-03541-9. Cancer Cell Int. 2024. PMID: 39468521 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36,002 results

Search Page

Filters